Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03132337 · ClinicalTrials.gov registry record
Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 80
- Enrollment target
NCT03132337 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 80 participants.
The verdict
NCT03132337 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The goal of this is to learn more about stem cell transplant and complications that some people have after their transplants, in particular sinusoidal obstruction syndrome (SOS), also called veno-occlusive disease of the liver.
Interventions
- OTHER Serial Blood Draws
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2021-01-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03132337
The ClinicalTrials.gov registry entry for NCT03132337 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Serial Blood Draws is the first listed.
NCT03132337 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03132337 about?
NCT03132337 is a clinical study titled "Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study". The goal of this is to learn more about stem cell transplant and complications that some people have after their transplants, in particular sinusoidal obstruction syndrome (SOS), also called veno-occlusive disease of the liver.
What is the current status of trial NCT03132337?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2017-04-01. Estimated completion is 2021-01-14.
What interventions are being tested in trial NCT03132337?
The interventions under investigation include: Serial Blood Draws (OTHER).
Who is sponsoring clinical trial NCT03132337?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.